The immunoglobulin E receptor: Expression and regulation

Edward R. Conner; Sarbjit S. Saini

doi:10.1007/s11882-005-0037-5

The immunoglobulin E receptor: Expression and regulation

Edward R. Conner, Sarbjit S. Saini

School of Medicine

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The interaction of immunoglobulin E (IgE) and its receptors is critical for the manifestation of allergic disease. Currently, IgE receptors include the high-affinity FcεRI and the low-affinity FcεRII. FcεRI is a tetrameric or trimeric complex, and each has distinct expression patterns and unique functional consequences. In general, serum levels of IgE regulate FcεRI expression, and novel therapies that lower the concentration of IgE have provided insights into the contribution of this receptor in allergic disease. Newer therapies targeting FcεRI-signaling elements and the low-affinity IgE receptor, FcεRII (CD23), are being developed.

Original language	English (US)
Pages (from-to)	191-196
Number of pages	6
Journal	Current allergy and asthma reports
Volume	5
Issue number	3
DOIs	https://doi.org/10.1007/s11882-005-0037-5
State	Published - May 2005

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Access to Document

10.1007/s11882-005-0037-5

Cite this

@article{5495a5fe7ef6476db9ffda288f6bc2d5,

title = "The immunoglobulin E receptor: Expression and regulation",

abstract = "The interaction of immunoglobulin E (IgE) and its receptors is critical for the manifestation of allergic disease. Currently, IgE receptors include the high-affinity FcεRI and the low-affinity FcεRII. FcεRI is a tetrameric or trimeric complex, and each has distinct expression patterns and unique functional consequences. In general, serum levels of IgE regulate FcεRI expression, and novel therapies that lower the concentration of IgE have provided insights into the contribution of this receptor in allergic disease. Newer therapies targeting FcεRI-signaling elements and the low-affinity IgE receptor, FcεRII (CD23), are being developed.",

author = "Conner, {Edward R.} and Saini, {Sarbjit S.}",

year = "2005",

month = may,

doi = "10.1007/s11882-005-0037-5",

language = "English (US)",

volume = "5",

pages = "191--196",

journal = "Current allergy and asthma reports",

issn = "1529-7322",

publisher = "Current Medicine Group",

number = "3",

}

TY - JOUR

T1 - The immunoglobulin E receptor

T2 - Expression and regulation

AU - Conner, Edward R.

AU - Saini, Sarbjit S.

PY - 2005/5

Y1 - 2005/5

N2 - The interaction of immunoglobulin E (IgE) and its receptors is critical for the manifestation of allergic disease. Currently, IgE receptors include the high-affinity FcεRI and the low-affinity FcεRII. FcεRI is a tetrameric or trimeric complex, and each has distinct expression patterns and unique functional consequences. In general, serum levels of IgE regulate FcεRI expression, and novel therapies that lower the concentration of IgE have provided insights into the contribution of this receptor in allergic disease. Newer therapies targeting FcεRI-signaling elements and the low-affinity IgE receptor, FcεRII (CD23), are being developed.

AB - The interaction of immunoglobulin E (IgE) and its receptors is critical for the manifestation of allergic disease. Currently, IgE receptors include the high-affinity FcεRI and the low-affinity FcεRII. FcεRI is a tetrameric or trimeric complex, and each has distinct expression patterns and unique functional consequences. In general, serum levels of IgE regulate FcεRI expression, and novel therapies that lower the concentration of IgE have provided insights into the contribution of this receptor in allergic disease. Newer therapies targeting FcεRI-signaling elements and the low-affinity IgE receptor, FcεRII (CD23), are being developed.

UR - http://www.scopus.com/inward/record.url?scp=20044386905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044386905&partnerID=8YFLogxK

U2 - 10.1007/s11882-005-0037-5

DO - 10.1007/s11882-005-0037-5

M3 - Review article

C2 - 15842956

AN - SCOPUS:20044386905

SN - 1529-7322

VL - 5

SP - 191

EP - 196

JO - Current allergy and asthma reports

JF - Current allergy and asthma reports

IS - 3

ER -

The immunoglobulin E receptor: Expression and regulation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this